doi: 10.1038/nature19796 189 CourtneyKDInfanteJRLamETFiglinRARiniBIBrugarolasJet al
This makes it more cost-effective and convenient for research purposes
However, brand trust, IP defense, and clinical validation will remain Novo and Lillys strongest moats in premium markets such as the USA, EU, and Japan, where regulatory standards and reimbursement frameworks still favor established innovators
The limited treatment landscape has created significant interest in repurposing existing drugs, particularly glucagon-like peptide-1 (GLP-1) receptor agonists, which address multiple metabolic pathways implicated in fatty liver disease
Neurological Function: It improves nerve function and may help treat conditions like neuropathy, neuralgia, and other nerve disorders